公司問答 | 光庫科技:公司主要產品為光纖激光器件、光通訊器件和鈮酸鋰調製器件等
格隆匯6月16日丨有投資者在互動平台向光庫科技公司提問:請問公司是否有產品可以用於vr/ar/mr領域?光庫科技迴應:公司主要產品為光纖激光器件、光通訊器件和鈮酸鋰調製器件等,其中光纖激光器件主要應用於光纖激光器、激光雷達、無人駕駛等領域;光通訊器件主要應用於密集波分複用傳輸、數據中心、雲計算、5G 產業鏈等領域;鈮酸鋰調製器件主要應用於超高速幹線光通信網、超高速數據中心、人工智能、超算中心、海底光通信網、城域核心網、微波光子、測試及科研等領域,
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.